| Literature DB >> 28149354 |
Thomas Ian Gee1, Nicholas Caplan2, Karl Christian Gibbon3, Glyn Howatson2, Kevin Grant Thompson4.
Abstract
This study aimed to determine the effects of a short-term, strength training intervention, typically undertaken by club-standard rowers, on 2,000 m rowing performance and strength and power development. Twenty-eight male rowers were randomly assigned to intervention or control groups. All participants performed baseline testing involving assessments of muscle soreness, creatine kinase activity (CK), maximal voluntary contraction (leg-extensors) (MVC), static-squat jumps (SSJ), counter-movement jumps (CMJ), maximal rowing power strokes (PS) and a 2,000 m rowing ergometer time-trial (2,000 m) with accompanying respiratory-exchange and electromyography (EMG) analysis. Intervention group participants subsequently performed three identical strength training (ST) sessions, in the space of five days, repeating all assessments 24 h following the final ST. The control group completed the same testing procedure but with no ST. Following ST, the intervention group experienced significant elevations in soreness and CK activity, and decrements in MVC, SSJ, CMJ and PS (p < 0.01). However, 2,000 m rowing performance, pacing strategy and gas exchange were unchanged across trials in either condition. Following ST, significant increases occurred for EMG (p < 0.05), and there were non-significant trends for decreased blood lactate and anaerobic energy liberation (p = 0.063 - 0.086). In summary, club-standard rowers, following an intensive period of strength training, maintained their 2,000 m rowing performance despite suffering symptoms of muscle damage and disruption to muscle function. This disruption likely reflected the presence of acute residual fatigue, potentially in type II muscle fibres as strength and power development were affected.Entities:
Keywords: endurance performance; muscle damage; muscle function; recovery; resistance training
Year: 2016 PMID: 28149354 PMCID: PMC5260651 DOI: 10.1515/hukin-2015-0153
Source DB: PubMed Journal: J Hum Kinet ISSN: 1640-5544 Impact factor: 2.193
The design of a strength training session and mean ± standard deviation of 1 RM achieved by the intervention group participants on the exercises featured
| Exercise | Sets x reps | % 1 RM / weight used | 1 RM achieved (kg) |
|---|---|---|---|
| Snatch grip high pull | 4x5 | 85% | 60 (7.5) |
| Clean | 4x5 | 85% | 75 (10) |
| Back squat | 4x5 | 85% | 105 (12.5) |
| Romanian deadlift | 3x8 | 75% of squat 1 | - |
| RM | |||
| Bench press | 3x5 | 85% | 75 (12.5) |
| Bench pull | 3x5 | 85% | 77.5 (10) |
Mean ± standard deviation rounded to nearest 2.5 kg increment
Comparison of 2,000 m performance, physiological measures, strength and power tests and markers of muscle damage across baseline and follow up trials for both groups
| Measure | Intervention | Control | ||
|---|---|---|---|---|
| Baseline | Follow up | Baseline | Follow up | |
| 2,000 m (min:s) | 6:46.3 (0:07.9) | 6:46.3 (0:08.8) | 6:45.3 (0:12.2) | 6:43.7 (0:11.4) |
| 4.99 (0.55) | 5.14 (0.38) | 5.04 (0.35) | 4.92 (0.39) | |
| [LA-] (mmol·PL-1) | 16.8 (2.6) | 15.7 (2.9) | 17.3 (3.5) | 17.8 (4.1) |
| RPE | 18 (1) | 18 (1) | 17 (1) | 17 (1) |
| MVC (N) | 569 (68) | 533 (61) | 596 (82) | 580 (81) |
| SSJ (cm) | 32.6 (4.0) | 29.8 (3.9) | 31.9 (5.7) | 31.2 (5.6) |
| CMJ (cm) | 35.6 (4.3) | 32.7 (4.0) | 33.8 (5.9) | 33.9 (6.5) |
| PS (W) | 523 (51) | 491 (49) | 511 (47) | 509 (45) |
| Muscle soreness | 2.2 (2.3) | 4.2 (1.3) | 1.0 (1.0) | 1.1 (1.4) |
| CK (U/L) | 188 (125) | 523 (348) | 195 (127) | 190 (105) |
Significant difference from the baseline trial (p < 0.05).
† = Trend for mean difference compared to the baseline trial (p = 0.051-0.10).
Figure 1Anaerobic and aerobic contributions to total power (watts) and a stroke rate (strokes·min-1) for baseline and follow trials during successive 500 m stages of the 2,000 m time trial for the intervention (n = 11; errors occurred during breath-by-breath measurement for 3 participants) and control groups (n = 14). * Significant difference between baseline and follow-up trials p < 0.05. † Trend for a significant difference between intervention baseline and follow-up trials p < 0.10